Delivery Order SPE2DB22D2211-SPE2DB25FRWTY
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with a ceiling value of $3,265.08. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $1,597.14 and an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,212.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 11, 2025. This competitive award, issued on a firm fixed price basis, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical distributor,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This competitive award, valued at $7,167.84 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The ultimate completion date is set for September 23, 2025....
- The Defense Logistics Agency awarded a $1,967.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $7,583.88 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $4,531.80. This firm fixed-price delivery order, issued on June 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $31,664.53 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml units), with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRWTYDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. Mounjaro is a diabetes medication used for glycemic control, consistent with the company's portfolio of pharmaceutical deliveries across military and veteran healthcare systems. This delivery order was issued without set-aside designation, reflecting open competition and the contractor's demonstrated capability to meet federal pharmaceutical procurement standards. AmerisourceBergen's prime IDC with DLA Troop Support Medical serves as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a child order under this larger contract vehicle, this Mounjaro delivery represents a routine pharmaceutical fulfillment supporting military healthcare needs within the broader defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.4k | 5/7/25 |